The purpose of this research is to see if the use of tamsulosin can decrease both the incidence and duration of urinary retention, as well as hospital length of stay following spine surgery.
Cervical Laminectomy
Cervical Posterior Fusion
Cervical Anterior/Posterior Fusion
Lumbar Laminectomy
Cervical Anterior Discectomy and Fusion
Cervical Anterior Corpectomy
Cervical Posterior Discectomy
Cervical Foraminotomy
Parallel
Uroselective alpha-1-adrenergic receptor antagonist
DrugSubjects will receive Tamsulosin (0.4 mg daily) beginning 5 days prior to surgery and for the duration of the postoperative hospital stay (approximately 8-12 days)
Placebo
Other interventionSubjects will receive placebo beginning 5 days prior to surgery and for the duration of the postoperative hospital stay (approximately 8-12 days)
Number of incidences of POUR (Postoperative urinary retention)
Total number of incidences of POUR (Postoperative urinary retention). POUR is defined as any of the following: estimated post-void residual (PVR) volume of urine greater than or equal to 300 mL; estimated retention urine volume of greater than or equal to 500 mL in patients unable to void; or patients experiencing discomfort or distension and unable to void with lesser residual urine volume than 500 ml.
Duration of POUR (Postoperative urinary retention)
Duration subjects experience postoperative urinary retention, reported in days
Number of intermittent catheterizations in those with urinary retention
Total number of catheterizations performed in subjects who experience urinary retention
Incidence of UTI (urinary tract infection)
Number of subjects to be diagnosed with a UTI (urinary tract infection) post-operatively
Duration of hospital stay
Total length of time subjects remain inpatient post-procedure, reported in days.
Click on the lead sponsor to view all of their trials.
